샘플 요청 목록

 카트 문의
시장보고서
상품코드
1594913

세계의 단백질 공학 시장

Protein Engineering
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 81 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

단백질 공학 세계 시장은 2030년까지 78억 달러에 달할 것으로 예상됩니다

2023년 30억 달러로 추정되는 단백질 공학 세계 시장은 2030년에는 78억 달러에 달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 14.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 단백질 공학 기기는 이 보고서에서 분석한 부문 중 하나이며, CAGR 13.8%를 기록하여 분석 기간 종료 시점에 33억 달러에 도달할 것으로 예상됩니다. 단백질 공학 시약 부문의 성장률은 분석 기간 동안 CAGR 14.7%로 추정됩니다.

미국 시장은 7억 7,990만 달러로 추정, 중국은 CAGR 18.9%로 성장 전망

미국의 단백질 공학 시장은 2023년 7억 7,990만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 18.9%의 연평균 복합 성장률(CAGR)을 기록하여 2030년까지 20억 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 10.0%와 12.2%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 연평균 10.9%의 성장률을 보일 것으로 예상됩니다.

세계 단백질 공학 시장 - 주요 동향 및 촉진요인 요약

단백질 공학은 바이오 의약품의 미래를 어떻게 형성하고 있는가?

단백질 공학은 효능, 안정성, 표적 특이성을 향상시킨 맞춤형 치료용 단백질을 개발할 수 있게 함으로써 바이오 의약품에 혁명을 불러일으키고 있습니다. 과학자들은 단백질의 구조를 조작하여 특정 질병 치료에 최적화된 특성을 가진 단일 클론 항체, 효소 및 기타 치료용 단백질을 생산할 수 있습니다. 예를 들어, 단일클론항체는 암, 자가면역질환, 감염성 질환과 싸우는 데 있어 표적 외 효과를 줄이고 환자 치료 결과를 개선하는 표적 치료제를 제공하는 귀중한 역할을 하고 있습니다. 마찬가지로 효소 보충 요법도 단백질 공학의 응용 분야 중 하나이며, 고셔병이나 파브리병과 같은 유전성 질환의 치료에 필수적입니다. 단백질 공학은 백신 개발에도 큰 영향을 미치고 있으며, 조작된 단백질은 바이러스 위협에 대한 백신에 사용되어 면역 반응과 다양한 전달 형태에서의 안정성을 향상시키고 있습니다. 단백질을 분자 수준에서 맞춤화할 수 있는 가능성으로 인해 단백질 공학은 개인의 유전적 체질에 맞게 치료가 이루어지고, 치료 성공률을 높이고 부작용을 감소시키는 정밀의료의 핵심으로 자리매김하고 있습니다. 바이오 제약회사들이 표적 치료법을 추구하는 가운데, 단백질 공학이 최전선에 서서 혁신적인 의약품과 치료법을 더 빨리, 더 효과적으로 시장에 출시할 수 있도록 돕고 있습니다.

합성생물학은 단백질 공학의 혁신에서 어떤 역할을 하는가?

합성생물학은 단백질 공학의 강력한 도구가 되어 연구자들이 특정 산업, 환경 및 의료적 요구에 맞는 새로운 기능성 단백질을 설계할 수 있게 해주며, CRISPR 및 TALEN과 같은 유전자 편집 기술의 발전으로 단백질의 구조를 정밀하게 변경하여 새로운 기능을 창출하고 단백질 공학의 용도를 확장하고 있습니다. 새로운 기능을 창출하여 단백질 공학의 용도를 넓혀가고 있습니다. 합성생물학은 또한 산업 공정에 사용되는 지속 가능한 효소의 개발을 촉진하여 가혹한 화학물질을 환경 친화적인 바이오 촉매로 대체하고 있습니다. 예를 들어, 섬유 산업, 세제 산업 및 바이오연료 산업에서 인공 효소가 널리 사용되어 에너지 소비를 줄이고 폐기물을 줄이며 효율성을 향상시키는 데 도움이되었습니다. 또한, 합성생물학은 계산 모델과 하이스루풋 스크리닝을 통해 과학자들이 극한의 온도와 pH 수준과 같은 가혹한 조건에서 더 높은 안정성과 기능성을 보이는 단백질을 생산할 수 있게 해줍니다. 이렇게 설계된 단백질은 환경 정화에도 유용하다는 것이 입증되고 있으며, 오염물질을 분해하거나 이산화탄소를 회수하도록 설계된 단백질이 환경 파괴를 완화하기 위해 도입되고 있습니다. 합성생물학과 단백질 공학의 시너지 효과로 단백질은 상상할 수 있는 모든 용도에 맞게 설계할 수 있는 혁신의 가능성을 넓혀주며 모든 산업에서 필수적인 요소로 자리 잡고 있습니다.

AI와 머신러닝은 단백질 공학에 어떤 변화를 가져올 것인가?

AI와 머신러닝은 설계 및 최적화 과정을 크게 가속화함으로써 단백질 공학에 변화를 일으키고 있습니다. 기존 단백질 공학은 원하는 단백질의 특성을 얻기 위해 수많은 반복을 거쳐야 하는 시간이 많이 소요되는 분야였습니다. 그러나 AI 알고리즘의 도입으로 데이터 기반 예측을 통해 단백질의 거동을 모델링함으로써 이러한 복잡성을 획기적으로 줄이고, 연구자들은 구조적 상호 작용과 변형에 대한 놀라운 정확도로 예측할 수 있게 되었습니다. 단백질 데이터로 훈련된 머신러닝 알고리즘은 단백질의 접힘, 안정성, 기능을 예측할 수 있어 실험적 시행착오를 줄일 수 있습니다. 기업 및 연구기관은 이제 AI 기반 설계 도구를 가상 스크리닝에 활용하여 물리적으로 테스트하기 전에 단백질 구조를 최적화할 수 있습니다. 이는 신약 개발에 매우 유용하며, AI는 단백질 표적을 신속하게 식별하고 치료제 개발을 가속화하는 데 도움이 되고 있습니다. 또한, 머신러닝은 특정 특성을 가진 단백질을 진화시키기 위해 자연선택을 모방하는 과정인 정방향 진화의 활용을 촉진하고 있습니다. 이 기술을 AI 기반 예측 모델링과 결합하면 과학자들은 단백질의 효율성과 안정성을 획기적으로 향상시킬 수 있습니다. 단백질 공학에서 AI와 머신러닝의 통합은 단백질 변형의 정확성을 향상시킬 뿐만 아니라 새로운 단백질의 신속한 개발을 가능하게 하여 이 분야의 과학적 발견에 대한 접근 방식에 혁명을 가져올 것입니다.

단백질 공학 시장의 성장은 몇 가지 요인에 의해 주도됩니다

단백질 공학 시장의 성장은 기술 발전, 최종 용도 확대, 소비자 수요의 진화 등 여러 요인에 의해 주도되고 있으며, CRISPR 유전자 편집, 하이스루풋 스크리닝, AI 기반 예측 모델링과 같은 혁신은 특정 기능을 가진 단백질의 설계를 용이하게 하여 신약 개발, 진단 및 산업 응용 분야에 새로운 길을 열어주고 있습니다. 설계가 용이해지면서 신약개발, 진단, 산업적 활용을 위한 새로운 길이 열리고 있습니다. 제약, 농업, 식음료, 환경 과학과 같은 최종 이용 산업은 질병 치료, 지속 가능한 생산, 환경 정화를 위한 맞춤형 솔루션을 제공하기 위해 인공 단백질을 점점 더 많이 채택하고 있습니다. 예를 들어, 제약 산업에서 생물학적 제제에 대한 수요가 증가함에 따라, 특히 종양학 및 면역학 분야에서 보다 효과적이고 부작용이 적은 질병을 표적으로 삼을 수 있는 인공 단백질에 대한 요구가 증가하고 있습니다. 또한, 지속 가능하고 친환경적인 제품에 대한 소비자의 관심은 생분해성 포장재부터 식물성 대체 식품에 이르기까지 일상 생활용품에 사용되는 생물공학 단백질의 개발을 촉진하고 있습니다. 환경 과학 분야에서는 오염물질을 분해하거나 온실가스를 포집하도록 설계된 단백질이 기후 변화 완화를 위한 노력에 적용되고 있습니다. 또한, 개인 맞춤형 의료의 부상과 정밀 진단의 발전은 환자별 치료 및 진단에 인공 단백질의 사용을 가속화하여 시장 잠재력을 더욱 확대시키고 있습니다. 이러한 추세는 단백질 공학이 세계 과제와 소비자 기대에 부응하는 데 있어 단백질 공학이 변혁적인 역할을 할 것임을 분명히 하며, 다방면에 걸친 단백질 공학의 성장을 가속하고 있습니다.

부문

제품(장비, 시약, 소프트웨어 & 서비스), 기술(합리적 단백질 설계, 유도 진화, 하이브리드 접근법), 최종 사용처(제약 & 생명공학 기업, 계약 연구 기관, 학술 연구 기관)

조사 대상 기업 예시(18개사)

  • Abzena, Ltd.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Codexis, Inc.
  • Creative Biolabs
  • Danaher Corporation
  • Enantis S.R.O.
  • GE Healthcare
  • Genscript Biotech Corporation
  • Innovagen AB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Perkinelmer, Inc.
  • Phynexus, Inc.
  • Phynexus, Inc.
  • Promega Corporation
  • Proteogenix
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.12.02

Global Protein Engineering Market to Reach US$7.8 Billion by 2030

The global market for Protein Engineering estimated at US$3.0 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Protein Engineering Instruments, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Protein Engineering Reagents segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$779.9 Million While China is Forecast to Grow at 18.9% CAGR

The Protein Engineering market in the U.S. is estimated at US$779.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 18.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 12.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Global Protein Engineering Market - Key Trends & Drivers Summarized

How Is Protein Engineering Shaping the Future of Biopharmaceuticals?

Protein engineering is revolutionizing biopharmaceuticals by enabling the development of tailored therapeutic proteins with enhanced effectiveness, stability, and target specificity. By manipulating protein structures, scientists can create monoclonal antibodies, enzymes, and other therapeutic proteins with optimized properties for treating specific diseases. Monoclonal antibodies, for instance, have become invaluable in the fight against cancer, autoimmune diseases, and infectious diseases, providing targeted therapies that reduce off-target effects and improve patient outcomes. Similarly, enzyme replacement therapies, another application of protein engineering, are essential for treating genetic disorders like Gaucher’s disease and Fabry disease. Protein engineering’s impact on vaccine development is also significant, with engineered proteins being used in vaccines against viral threats, enhancing immune response and stability in various delivery formats. The potential to customize proteins on a molecular level has positioned protein engineering as a cornerstone of precision medicine, where treatments are increasingly tailored to an individual's genetic makeup, increasing therapeutic success and reducing side effects. As biopharmaceutical companies continue to seek targeted therapies, protein engineering is at the forefront, helping bring innovative drugs and therapies to market faster and with improved efficacy.

What Role Does Synthetic Biology Play in Protein Engineering Innovation?

Synthetic biology has become a powerful tool within protein engineering, allowing researchers to design proteins with novel functionalities that meet specific industrial, environmental, and medical needs. Advances in gene-editing technologies like CRISPR and TALEN have made it easier to modify protein structures precisely, creating new capabilities and expanding protein engineering’s applications. Synthetic biology has also propelled the development of sustainable enzymes used in industrial processes, replacing harsh chemicals with environmentally friendly biocatalysts. For instance, engineered enzymes are now widely used in the textile, detergent, and biofuel industries, where they help reduce energy consumption, lower waste production, and improve efficiency. Moreover, by incorporating computational models and high-throughput screening, synthetic biology enables scientists to create proteins that exhibit enhanced stability and functionality under challenging conditions, such as extreme temperatures or pH levels. These engineered proteins are also proving valuable in environmental cleanup, where proteins designed to degrade pollutants or capture carbon dioxide are being deployed to mitigate environmental damage. The synergy between synthetic biology and protein engineering is expanding the possibilities for innovation, allowing proteins to be designed for virtually any application imaginable, making them indispensable across industries.

How Are AI and Machine Learning Transforming Protein Engineering?

AI and machine learning are transforming protein engineering by significantly speeding up the design and optimization processes. Traditionally, protein engineering was a time-intensive field, requiring countless iterations to achieve desired protein properties. However, the introduction of AI algorithms has dramatically reduced this complexity by using data-driven predictions to model protein behavior, enabling researchers to foresee structural interactions and modifications with remarkable accuracy. Machine learning algorithms trained on protein data have made it possible to predict protein folding, stability, and function, thus reducing experimental trial and error. Companies and research institutions are now able to utilize AI-driven design tools for virtual screening, optimizing protein structures before they are ever physically tested. This has proved invaluable in drug discovery, where AI helps identify protein targets quickly, accelerating the development of therapeutics. Additionally, machine learning is facilitating the use of directed evolution, a process that mimics natural selection to evolve proteins with specific characteristics. This technique, when combined with AI-based predictive modeling, allows scientists to enhance proteins’ efficiency and stability exponentially. The integration of AI and machine learning in protein engineering not only improves the accuracy of protein modifications but also enables the rapid development of novel proteins, revolutionizing the approach to scientific discovery in this field.

The Growth in the Protein Engineering Market Is Driven by Several Factors…

The growth in the protein engineering market is driven by several factors, including advances in technology, expanding end-use applications, and evolving consumer demands. Technological innovations such as CRISPR gene editing, high-throughput screening, and AI-powered predictive modeling are making it easier to design proteins with specific functions, opening new avenues in drug discovery, diagnostics, and industrial applications. End-use industries like pharmaceuticals, agriculture, food and beverage, and environmental science are increasingly adopting engineered proteins, as they offer tailored solutions for disease treatment, sustainable production, and environmental cleanup. For example, the growing demand for biologics in the pharmaceutical industry is driving the need for engineered proteins that can target diseases more effectively and with fewer side effects, particularly in fields like oncology and immunology. Additionally, consumer interest in sustainable and eco-friendly products is encouraging the development of bioengineered proteins for use in everyday products, from biodegradable packaging to plant-based food alternatives. In environmental science, proteins engineered to degrade pollutants or capture greenhouse gases are finding applications in climate change mitigation efforts. Furthermore, the rise of personalized medicine and the push for precision diagnostics are accelerating the use of engineered proteins in patient-specific therapies and diagnostics, further expanding the market’s potential. These converging trends underscore the transformative role of protein engineering in addressing both global challenges and consumer expectations, fueling its growth across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Protein Engineering market in terms of US$ Thousand by the following End-Use; Product; Technology, and Geographic Regions/Countries:

Segments:

Product (Instruments, Reagents, Software & Services); Technology (Rational Protein Design, Directed Evolution, Hybrid Approach); End-Use (Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 18 Featured) -

  • Abzena, Ltd.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Codexis, Inc.
  • Creative Biolabs
  • Danaher Corporation
  • Enantis S.R.O.
  • GE Healthcare
  • Genscript Biotech Corporation
  • Innovagen AB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Perkinelmer, Inc.
  • Phynexus, Inc. (A Part of Biotage)
  • Promega Corporation
  • Proteogenix
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Protein Engineering - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Therapeutic Proteins in Biopharmaceuticals Drives Growth in Protein Engineering Solutions
    • Increased Focus on Precision Medicine Spurs Development of Customized and Targeted Protein Therapies
    • Advances in CRISPR and Gene Editing Technologies Expand Capabilities in Protein Engineering for Disease Treatment
    • Growth of Monoclonal Antibodies and Enzyme Replacement Therapies Elevates Market for Engineered Proteins
    • Increased Use of Protein Engineering in Vaccine Development Supports Market, Especially for Viral Disease Prevention
    • Rising Investment in Synthetic Biology Enhances Market for Engineered Proteins with Novel Functionalities
    • Expansion of Structural Biology and Computational Modeling Improves Accuracy and Efficiency in Protein Design
    • High Demand for Sustainable Industrial Enzymes Spurs Development of Engineered Proteins for Industrial Applications
    • Increased Focus on Biocatalysis in Pharmaceutical Manufacturing Drives Use of Custom Enzymes and Proteins
    • Growth in Agricultural Biotechnology Fuels Demand for Engineered Proteins in Crop Protection and Yield Enhancement
    • Advances in AI and Machine Learning Enhance Predictive Modeling for Protein Function and Stability
    • Rising Demand for Protein-Based Biosensors and Diagnostic Tools Expands Applications in Clinical and Environmental Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Rational Protein Design by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Rational Protein Design by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Rational Protein Design by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Directed Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Directed Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Directed Evolution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hybrid Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hybrid Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hybrid Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Protein Engineering Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Protein Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Protein Engineering by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Protein Engineering by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • INDIA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Protein Engineering by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Protein Engineering by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
  • AFRICA
    • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제